Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T15:31:45.247Z.
Calculation as of: 2026-10-06T15:31:45.247Z.
Quote observation: 2026-10-06T15:30:30.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 6dae1ed753b385efcb651dd8f32a10b6f9886011747f410ddce9f57bee9a14c9
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Dianthus Therapeutics, Inc.
Market Cap
$4.91B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.89B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.91B
Free Cash Flow Yield
N/A
TTM Avg
1.04%
3Y Avg
1.04%
5Y Avg
1.04%
Market Cap
$4.75B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.68B
Free Cash Flow Yield
3.72%
TTM Avg
4.28%
3Y Avg
3.98%
5Y Avg
3.98%
Market Cap
$5.08B
Free Cash Flow Yield
4.01%
TTM Avg
3.85%
3Y Avg
2.74%
5Y Avg
2.55%
Market Cap
$4.65B
Free Cash Flow Yield
N/A
TTM Avg
5.99%
3Y Avg
5.19%
5Y Avg
4.45%
Market Cap
$4.62B
Free Cash Flow Yield
0.72%
TTM Avg
0.53%
3Y Avg
0.53%
5Y Avg
0.53%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Dianthus Therapeutics, Inc. (DNTH) | $4.91B | N/A | N/A | N/A | N/A |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.89B | N/A | N/A | N/A | N/A |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.91B | N/A | 1.04% | 1.04% | 1.04% |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.75B | N/A | N/A | N/A | N/A |
| LifeStance Health Group, Inc. (LFST)vs › | $4.68B | 3.72% | 4.28% | 3.98% | 3.98% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.08B | 4.01% | 3.85% | 2.74% | 2.55% |
| Option Care Health, Inc. (OPCH)vs › | $4.65B | N/A | 5.99% | 5.19% | 4.45% |
| Erasca, Inc. (ERAS)vs › | $5.15B | N/A | N/A | N/A | N/A |
| BillionToOne, Inc. (BLLN)vs › | $4.62B | 0.72% | 0.53% | 0.53% | 0.53% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.23B | N/A | 3.62% | 3.62% | 3.62% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
